USA - NASDAQ:EXOZ - US4618741098 - Common Stock
The current stock price of EXOZ is 14.47 USD. In the past month the price increased by 44.23%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.01 | 393.01B | ||
AMGN | AMGEN INC | 13.09 | 153.65B | ||
GILD | GILEAD SCIENCES INC | 14.74 | 141.56B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 22.62 | 98.23B | ||
REGN | REGENERON PHARMACEUTICALS | 12.97 | 62.75B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.45B | ||
ARGX | ARGENX SE - ADR | 79.48 | 45.09B | ||
ONC | BEONE MEDICINES LTD-ADR | 5.84 | 39.75B | ||
INSM | INSMED INC | N/A | 30.60B | ||
NTRA | NATERA INC | N/A | 24.86B | ||
BNTX | BIONTECH SE-ADR | N/A | 23.13B | ||
BIIB | BIOGEN INC | 8.9 | 20.89B |
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
EXOZYMES INC
750 Royal Oaks Dr
Monrovia California CALIFORNIA US
Employees: 31
Phone: 16264151488
The current stock price of EXOZ is 14.47 USD. The price increased by 5.24% in the last trading session.
The exchange symbol of EXOZYMES INC is EXOZ and it is listed on the Nasdaq exchange.
EXOZ stock is listed on the Nasdaq exchange.
EXOZYMES INC (EXOZ) has a market capitalization of 121.40M USD. This makes EXOZ a Micro Cap stock.
EXOZYMES INC (EXOZ) currently has 31 employees.
EXOZYMES INC (EXOZ) has a support level at 9.15 and a resistance level at 14.48. Check the full technical report for a detailed analysis of EXOZ support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EXOZ does not pay a dividend.
EXOZYMES INC (EXOZ) will report earnings on 2025-11-12.
EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).
The outstanding short interest for EXOZYMES INC (EXOZ) is 0.67% of its float. Check the ownership tab for more information on the EXOZ short interest.
ChartMill assigns a technical rating of 7 / 10 to EXOZ.
ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -256.1% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -79.66% | ||
ROE | -106.54% | ||
Debt/Equity | 0.01 |